Nasal intermittent positive pressure ventilation (NIPPV)
Nasal intermittent positive pressure ventilation (NIPPV) is a medical device with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound
Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
NIPPV vs.nCPAP During LISA Procedure
Influence of Respiratory Rate Settings on CO2 Levels During Nasal Intermittent Positive Pressure Ventilation (NIPPV).
Work of Breathing During Non-invasive Ventilation in Premature Neonates
Clinical Trials (6)
Evaluation of Nasal Non Invasive Ventilation in Management of Neonates With Respiratory Distress Using Lung Ultrasound
Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
NIPPV vs.nCPAP During LISA Procedure
Influence of Respiratory Rate Settings on CO2 Levels During Nasal Intermittent Positive Pressure Ventilation (NIPPV).
Work of Breathing During Non-invasive Ventilation in Premature Neonates
A Study of Bi-Level Positive Airway Pressure (BIPAP) Versus Non Invasive Positive Pressure Ventilation (NIPPV) for Neonatal Respiratory Failure
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6